Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb
Core profile pages, annual revenue records, and related research hubs for this company.
Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$48.2B
Market Cap
$130.0B
Net Income
$7.1B
Employees
32,500
Bristol Myers Squibb reported $48.2B in FY2025 revenue and $7.1B in net income/profit attributable to the company or shareholders. In 2025 Bristol Myers Squibb reported $48.194B in total revenues and $7.054B of net earnings attributable to BMS, while its Growth Portfolio rose 17%.
Revenue Trend Analysis
YoY Change
-0.2%
2-Year CAGR
+3.5%
Peak Year
2024
Trend
Mostly Growing
Bristol-Myers Squibb Company has reported revenue across 3 fiscal years, compounding at +3.5% annually over 2 years. The most recent year saw a 0.2% decline versus the prior year. Revenue peaked in 2024 at $48.3B. Out of 2 reported periods, 1 showed growth and 1 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $48.2B | $7.1B | -0.2% |
| FY2024 | $48.3B | N/A | +7.3% |
| FY2023 | $45.0B | $8.0B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Bristol Myers Squibb is known for oncology, hematology, immunology, cardiovascular, neuroscience, cell therapy, and radiopharmaceutical medicines.
Bristol Myers Squibb reported $48.2B in FY2025 revenue.
Chris Boerner is the current CEO of Bristol Myers Squibb.
Bristol Myers Squibb has about 32,500 employees based on the latest annual reporting context.
The biggest risk is patent-cliff execution: generic pressure on legacy brands must be offset by launches such as Cobenfy, Opdivo Qvantig, Reblozyl, Breyanzi, and radiopharmaceutical programs.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Bristol-Myers Squibb Company Revenue & Financials." CorpDigest, https://corpdigest.com/company/bristol-myers-squibb/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Bristol-Myers Squibb Company reported $48B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/bristol-myers-squibb/financials" target="_blank" rel="noopener">CorpDigest — Bristol-Myers Squibb Company financials</a></div>